Generation and therapeutic efficacy of the novel Fc-modified cross-neutralizing human monoclonal antibodies against dengue virus
Preprint in bioRxiv (May 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Preprint in bioRxiv (May 2023)
Article in Frontiers in Cellular and Infection Microbiology (August 2021)